References
Kulaylat AN, Kulaylat AS, Schaefer EW, Mirkin K, Tinsley A, Williams E, et al. The Impact of Preoperative Anti-TNFα Therapy on Postoperative Outcomes Following Ileocolectomy in Crohn’s Disease. J Gastrointest Surg 2020. Jan 21. https://doi.org/10.1007/s11605-019-04334-6. Online ahead of print.
Lau C, Dubinsky M, Melmed G, Vasiliauskas E, Berel D, McGovern D, et al. The impact of preoperative serum anti-TNFα therapy levels on early postoperative outcomes in inflammatory bowel disease surgery. Ann Surg 2015;261(3):487–96.
Brouquet A, Maggiori L, Zerbib P, Lefevre JH, Denost Q, Germain A, et al. Anti-TNF Therapy Is Associated with an Increased Risk of Postoperative Morbidity after Surgery for Ileocolonic Crohn Disease: Results of a Prospective Nationwide Cohort. Annals of Surgery. 2018;267(2):221–8.
Cohen B, Fleshner P, Kane S. Anti-tumor necrosis factor is not associated with postoperative infections: results from prospective cohort of ulcerative colitis and Crohn’s disease patients undergoing surgery to indentify risk factors for postoperative infections (PUCCINI). Gastroenterology 2019;156(6):S-80.
Quaresma AB, Yamamoto T, Kotze PG. Biologics and surgical outcomes in Crohn’s disease: is there a direct relationship?. Therap Adv Gastroenterol. 2020;Jul16;13:1756284820931738. https://doi.org/10.1177/1756284820931738. eCollection 2020.
Kotze PG, Saab MP, Saab B, da Silva Kotze LM, Olandoski M, Pinheiro LV, et al. Tumor Necrosis Factor Alpha Inhibitors Did Not Influence Postoperative Morbidity After Elective Surgical Resections in Crohn’s Disease. Dig Dis Sci 2017;62(2):456–64.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Dr. Queiroz received consulting fees from Janssen, Takeda and Abbvie. Dr. Kotze received consultancy fees and speaking honorarium from Abbvie, Janssen, Pfizer, Takeda, Ferring and Novartis. He also received scientific grants from Takeda and Pfizer. Dr. Perin has no conflicts of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Perin, R.L., Queiroz, N.S.F. & Kotze, P.G. Preoperative Anti-TNF Agents and Morbidity After Ileocolonic Resections in Crohn’s Disease: Are Biologics the Only Ones to Blame?. J Gastrointest Surg 25, 1352–1353 (2021). https://doi.org/10.1007/s11605-021-04976-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-021-04976-5